article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. As a result, it publicly promised that “ while the pandemic continues, Moderna will not enforce our COVID-19 related patents against those making vaccines intended to combat the pandemic.”

article thumbnail

The impact of COVID-19 on virtual trials

Mobi Health News

The need to accelerate virtual trials is just one takeout that Henry Levy, GM at Veeva Vault CDMS, talks about in an exclusive interview with MobiHealthNews, in which the impact of COVID-19 on the pharmaceutical industry is addressed.

COVID-19 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Gains and Pains of Using AI in the Pharmaceutical Industry

HIT Consultant

– Samsung reduces the time required to label lung X-Rays used to diagnose COVID-19 by 84% by using AI to identify and then label the most informative images first. . – Novartis uses machine learning to identify patient groups and predict their positive and adverse reactions to treatments.

article thumbnail

U.S. Hospitals Will Lose $323 Billion in 2020 – Before Accounting for Growing COVID Cases

Health Populi

health systems are projected to lose $323 billion in 2020 due to declining inpatient and outpatient volumes caused by the COVID-19 pandemic’s impact on the “normal” hospital business. Some hospitals in regions of these states are approaching full capacity in ICUs and COVID units. fall in outpatient volume.

COVID-19 127
article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

The selections feature topics ranging from how Wikipedia pages communicate drug efficacy information, to addressing pharmaceutical industry payments to physicians, to the frequency with which the Food and Drug Administration removes hazardous dietary supplements from the market. 2022 Jul 19:S0895-4356(22)00182-2.

COVID-19 130
article thumbnail

Clinical Trials in Healthcare Training

American Medical Compliance

The pharmaceutical industry relies on electronically captured data for drug evaluation, necessitating strict adherence to good data management practices. The COVID-19 pandemic further disrupted clinical research, halting ongoing trials and delaying new studies.

article thumbnail

How Pharma Startups Can Remain Competitive in Today’s Market

HIT Consultant

In the Pharmaceutical industry, one of the major gaps is an effective, and personalized customer experience. . The COVID-19 pandemic drastically affected the way consumers prefer to receive medication and medical services. pharmaceutical industry will be worth $ 685.45 Adopting and Leveraging Technology.